Stephen Simes, BSc, MBA

Stephen Simes (BSc, MBA) is the Chairman of the BioXL board and a seasoned leader in the biopharmaceutical industry. With extensive experience as a CEO and board member, Stephen has a proven track record in the management, financing, and governance of public biopharma companies, overseeing numerous FDA-approved and R&D-stage products. Throughout his career, he has successfully raised over $500 million through various financing transactions, product licensing agreements, and mergers and acquisitions. His strategic insights and leadership have been instrumental in driving growth and innovation within the biopharmaceutical sector.